1.
Full Text
DRESS syndrome with thrombotic microangiopathy revealing a Noonan syndrome: Case report
Medicine (United States), ISSN 0025-7974, 04/2018, Volume 97, Issue 15, p. e0297
The life-threatening drug rash with eosinophilia and systemic symptoms (DRESS) syndrome occurs most commonly after exposure to drugs, clinical features mimic...
fluindione | lymphangiomatosis | thrombotic thrombocytopenic purpura | Glucocorticoids - administration & dosage | Anticoagulants - administration & dosage | Drug Hypersensitivity Syndrome - diagnosis | Humans | Noonan Syndrome - physiopathology | Retroperitoneal Space - pathology | Male | Drug Hypersensitivity Syndrome - blood | Phenindione - administration & dosage | Lymphatic Abnormalities - etiology | Phenindione - adverse effects | Retroperitoneal Space - diagnostic imaging | Adult | Lymphatic Abnormalities - diagnosis | Drug Hypersensitivity Syndrome - etiology | Drug Hypersensitivity Syndrome - physiopathology | Diagnosis, Differential | Son of Sevenless Proteins - genetics | Anticoagulants - adverse effects | Noonan Syndrome - genetics | Phenindione - analogs & derivatives | Withholding Treatment | Thrombotic Microangiopathies - diagnosis | Mutation | Thrombotic Microangiopathies - etiology | Mediastinum - pathology | Mediastinum - diagnostic imaging | MEDICINE, GENERAL & INTERNAL | DISEASE | DRUG REACTION | EOSINOPHILIA | SYSTEMIC SYMPTOMS | Life Sciences | Human health and pathology | Dermatology | Pharmaceutical sciences
fluindione | lymphangiomatosis | thrombotic thrombocytopenic purpura | Glucocorticoids - administration & dosage | Anticoagulants - administration & dosage | Drug Hypersensitivity Syndrome - diagnosis | Humans | Noonan Syndrome - physiopathology | Retroperitoneal Space - pathology | Male | Drug Hypersensitivity Syndrome - blood | Phenindione - administration & dosage | Lymphatic Abnormalities - etiology | Phenindione - adverse effects | Retroperitoneal Space - diagnostic imaging | Adult | Lymphatic Abnormalities - diagnosis | Drug Hypersensitivity Syndrome - etiology | Drug Hypersensitivity Syndrome - physiopathology | Diagnosis, Differential | Son of Sevenless Proteins - genetics | Anticoagulants - adverse effects | Noonan Syndrome - genetics | Phenindione - analogs & derivatives | Withholding Treatment | Thrombotic Microangiopathies - diagnosis | Mutation | Thrombotic Microangiopathies - etiology | Mediastinum - pathology | Mediastinum - diagnostic imaging | MEDICINE, GENERAL & INTERNAL | DISEASE | DRUG REACTION | EOSINOPHILIA | SYSTEMIC SYMPTOMS | Life Sciences | Human health and pathology | Dermatology | Pharmaceutical sciences
Journal Article
Joint Bone Spine, ISSN 1297-319X, 2013, Volume 81, Issue 1, pp. 15 - 21
Abstract Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome, initially recognized as a serious form of cutaneous drug adverse reaction, is...
Internal Medicine | Rheumatology | DIHS | Cytomegalovirus | DRESS | Hypersensitivity | Toxic dermatitis | Epstein-Barr virus | HLA | Human Herpesvirus 6 | HUMAN-LEUKOCYTE ANTIGENS | DRUG REACTION | RHEUMATOLOGY | SYSTEMIC SYMPTOMS | ANTICONVULSANT HYPERSENSITIVITY SYNDROME | Human Herpesvirus | REPLICATION | REACTIVATION | EOSINOPHILIA | ASSOCIATION | HERPESVIRUS 6 INFECTION | Drug Hypersensitivity Syndrome - diagnosis | Drug Hypersensitivity Syndrome - virology | Humans | Middle Aged | Male | Drug Hypersensitivity Syndrome - therapy | Drug Hypersensitivity Syndrome - etiology | Antiviral agents | Immunogenetics | T cells | Health aspects
Internal Medicine | Rheumatology | DIHS | Cytomegalovirus | DRESS | Hypersensitivity | Toxic dermatitis | Epstein-Barr virus | HLA | Human Herpesvirus 6 | HUMAN-LEUKOCYTE ANTIGENS | DRUG REACTION | RHEUMATOLOGY | SYSTEMIC SYMPTOMS | ANTICONVULSANT HYPERSENSITIVITY SYNDROME | Human Herpesvirus | REPLICATION | REACTIVATION | EOSINOPHILIA | ASSOCIATION | HERPESVIRUS 6 INFECTION | Drug Hypersensitivity Syndrome - diagnosis | Drug Hypersensitivity Syndrome - virology | Humans | Middle Aged | Male | Drug Hypersensitivity Syndrome - therapy | Drug Hypersensitivity Syndrome - etiology | Antiviral agents | Immunogenetics | T cells | Health aspects
Journal Article
The Journal of the Association of Physicians of India, ISSN 0004-5772, 04/2019, Volume 67, Issue 4, p. 87
Carbamazepine was and still used extensively in clinical practice in varied indications can cause adverse drug reaction shaving diverse clinical manifestations...
Drug Hypersensitivity Syndrome - diagnosis | Exanthema | Humans | Eosinophilia | Carbamazepine | Fever
Drug Hypersensitivity Syndrome - diagnosis | Exanthema | Humans | Eosinophilia | Carbamazepine | Fever
Journal Article
Contact Dermatitis, ISSN 0105-1873, 04/2019, Volume 80, Issue 4, pp. 253 - 254
case report | drug reaction with eosinophilia and systemic symptoms/drug‐induced hypersensitivity syndrome (DRESS/DIHS) | Sjogren syndrome | levofloxacin | rheumatoid arthritis | systemic scleroderma | drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome (DRESS/DIHS) | ALLERGY | DERMATOLOGY | Rheumatoid factor | Allergy | Levofloxacin | Systemic scleroderma | Scleroderma (Disease) | Arthritis | Allergic reaction | Eosinophilia | Sjogren's syndrome | Rheumatoid arthritis | Hypersensitivity | Scleroderma
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2013, Volume 68, Issue 5, pp. 693.e1 - 693.e14
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome, also referred to as drug-induced hypersensitivity syndrome, is a distinct, potentially...
DRESS syndrome | drug-induced hypersensitivity syndrome | drug allergy | phenytoin hypersensitivity | eosinophilia | erythroderma | severe drug eruption | toxic epidermal necrolysis | HUMAN-HERPESVIRUS-6 REACTIVATION | ADVERSE DRUG-REACTIONS | VERSUS-HOST-DISEASE | DERMATOLOGY | CUTANEOUS REACTIONS | SYSTEMIC SYMPTOMS DRESS | INDUCED HYPERSENSITIVITY SYNDROME | STEVENS-JOHNSON-SYNDROME | T-CELLS | HERPESVIRUS 6 INFECTION | Drug Hypersensitivity - etiology | Drug Eruptions - etiology | Education, Medical, Continuing | Eosinophilia - etiology | Drug Eruptions - physiopathology | Humans | Drug Hypersensitivity - physiopathology | Eosinophilia - physiopathology | Syndrome | Index Medicus
DRESS syndrome | drug-induced hypersensitivity syndrome | drug allergy | phenytoin hypersensitivity | eosinophilia | erythroderma | severe drug eruption | toxic epidermal necrolysis | HUMAN-HERPESVIRUS-6 REACTIVATION | ADVERSE DRUG-REACTIONS | VERSUS-HOST-DISEASE | DERMATOLOGY | CUTANEOUS REACTIONS | SYSTEMIC SYMPTOMS DRESS | INDUCED HYPERSENSITIVITY SYNDROME | STEVENS-JOHNSON-SYNDROME | T-CELLS | HERPESVIRUS 6 INFECTION | Drug Hypersensitivity - etiology | Drug Eruptions - etiology | Education, Medical, Continuing | Eosinophilia - etiology | Drug Eruptions - physiopathology | Humans | Drug Hypersensitivity - physiopathology | Eosinophilia - physiopathology | Syndrome | Index Medicus
Journal Article
Current Opinion in Pulmonary Medicine, ISSN 1070-5287, 01/2015, Volume 21, Issue 1, pp. 74 - 79
PURPOSE OF REVIEWSome individuals share characteristics of asthma and chronic obstructive pulmonary disease (COPD). The asthma–COPD overlap syndrome (ACOS) has...
ACOS | Diagnosis | Asthma-COPD overlap syndrome | Asthma | COPD | EOSINOPHILIC AIRWAY INFLAMMATION | FLOW OBSTRUCTION | CLINICAL PHENOTYPES | diagnosis | asthma | RANDOMIZED CONTROLLED-TRIAL | FEATURES | COPD-ASTHMA | SPUTUM EOSINOPHILIA | RESPIRATORY SYSTEM | REVERSIBILITY | HEALTH | asthma-COPD overlap syndrome | Asthma - diagnosis | Pulmonary Disease, Chronic Obstructive - diagnosis | Prevalence | Asthma - physiopathology | Eosinophils - drug effects | Humans | Administration, Inhalation | Pulmonary Disease, Chronic Obstructive - physiopathology | Adrenal Cortex Hormones - therapeutic use | Asthma - drug therapy | Disease Progression | Sputum - immunology | Asthma - immunology | Polymorphism, Single Nucleotide | Receptors, G-Protein-Coupled - genetics | Inflammation - diagnosis | Respiratory Function Tests | Pulmonary Disease, Chronic Obstructive - immunology | Practice Guidelines as Topic | Pulmonary Disease, Chronic Obstructive - drug therapy
ACOS | Diagnosis | Asthma-COPD overlap syndrome | Asthma | COPD | EOSINOPHILIC AIRWAY INFLAMMATION | FLOW OBSTRUCTION | CLINICAL PHENOTYPES | diagnosis | asthma | RANDOMIZED CONTROLLED-TRIAL | FEATURES | COPD-ASTHMA | SPUTUM EOSINOPHILIA | RESPIRATORY SYSTEM | REVERSIBILITY | HEALTH | asthma-COPD overlap syndrome | Asthma - diagnosis | Pulmonary Disease, Chronic Obstructive - diagnosis | Prevalence | Asthma - physiopathology | Eosinophils - drug effects | Humans | Administration, Inhalation | Pulmonary Disease, Chronic Obstructive - physiopathology | Adrenal Cortex Hormones - therapeutic use | Asthma - drug therapy | Disease Progression | Sputum - immunology | Asthma - immunology | Polymorphism, Single Nucleotide | Receptors, G-Protein-Coupled - genetics | Inflammation - diagnosis | Respiratory Function Tests | Pulmonary Disease, Chronic Obstructive - immunology | Practice Guidelines as Topic | Pulmonary Disease, Chronic Obstructive - drug therapy
Journal Article
European Journal of Dermatology, ISSN 1167-1122, 9/2014, Volume 24, Issue 5, pp. 603 - 610
Wells’ syndrome is defined as an inflammatory disorder with the histopathological presence of eosinophilic infiltrates and flame figures in the absence of...
Churg-Strauss syndrome | Medicine & Public Health | Wells’ syndrome | Dermatology | eosinophilic leukocytoclastic vasculitis | Eosinophilic leukocytoclastic vasculitis | RECURRENT GRANULOMATOUS DERMATITIS | CELLULITIS | Wells' syndrome | SWEET SYNDROME | HYPEREOSINOPHILIC SYNDROME | INFECTION | PARVOVIRUS | FEBRILE NEUTROPHILIC DERMATOSIS | ASSOCIATION | DERMATOLOGY | Cellulitis - pathology | Humans | Middle Aged | Neutrophils | Churg-Strauss Syndrome - pathology | Male | Eosinophilia - pathology | Lymphocytes | Aged, 80 and over | Adult | Female | Aged | Child | Vasculitis, Leukocytoclastic, Cutaneous - pathology | Eosinophils
Churg-Strauss syndrome | Medicine & Public Health | Wells’ syndrome | Dermatology | eosinophilic leukocytoclastic vasculitis | Eosinophilic leukocytoclastic vasculitis | RECURRENT GRANULOMATOUS DERMATITIS | CELLULITIS | Wells' syndrome | SWEET SYNDROME | HYPEREOSINOPHILIC SYNDROME | INFECTION | PARVOVIRUS | FEBRILE NEUTROPHILIC DERMATOSIS | ASSOCIATION | DERMATOLOGY | Cellulitis - pathology | Humans | Middle Aged | Neutrophils | Churg-Strauss Syndrome - pathology | Male | Eosinophilia - pathology | Lymphocytes | Aged, 80 and over | Adult | Female | Aged | Child | Vasculitis, Leukocytoclastic, Cutaneous - pathology | Eosinophils
Journal Article
Annals of Allergy, Asthma & Immunology, ISSN 1081-1206, 2014, Volume 112, Issue 6, pp. 484 - 488
Abstract Objective To summarize the identified molecular and cellular mechanisms relevant to clinicians evaluating patients with hypereosinophilic syndrome...
Allergy and Immunology | CHURG-STRAUSS-SYNDROME | CHRONIC EOSINOPHILIC LEUKEMIA | MEPOLIZUMAB | IDIOPATHIC EOSINOPHILIA | ALLERGY | IMATINIB | TERM-FOLLOW-UP | CLASSIFICATION | DISORDERS | FIP1L1-PDGFRA FUSION | IMMUNOLOGY | T-CELLS | Hypereosinophilic Syndrome - drug therapy | Hypereosinophilic Syndrome - diagnosis | Cell Proliferation | Humans | Eosinophils - pathology | Hypereosinophilic Syndrome - pathology | Hypereosinophilic Syndrome - complications | Lymphoproliferative Disorders - etiology
Allergy and Immunology | CHURG-STRAUSS-SYNDROME | CHRONIC EOSINOPHILIC LEUKEMIA | MEPOLIZUMAB | IDIOPATHIC EOSINOPHILIA | ALLERGY | IMATINIB | TERM-FOLLOW-UP | CLASSIFICATION | DISORDERS | FIP1L1-PDGFRA FUSION | IMMUNOLOGY | T-CELLS | Hypereosinophilic Syndrome - drug therapy | Hypereosinophilic Syndrome - diagnosis | Cell Proliferation | Humans | Eosinophils - pathology | Hypereosinophilic Syndrome - pathology | Hypereosinophilic Syndrome - complications | Lymphoproliferative Disorders - etiology
Journal Article
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, ISSN 1610-0379, 10/2016, Volume 14, Issue 10, pp. 989 - 993
Summary A rare eosinophilic dermatosis, Wells syndrome, also referred to as eosinophilic cellulitis, is characterized by great clinical variability. Typical...
EOSINOPHILIC CELLULITIS | CHURG-STRAUSS-SYNDROME | SKIN | INTERLEUKIN-5 | T-CELLS | DERMATOLOGY | Diagnosis, Differential | Humans | Treatment Outcome | Dermatologic Agents - therapeutic use | Adrenal Cortex Hormones - therapeutic use | Cryopyrin-Associated Periodic Syndromes - drug therapy | Evidence-Based Medicine | Cryopyrin-Associated Periodic Syndromes - diagnostic imaging | Dermoscopy - methods | Eosinophilia - pathology | Cryopyrin-Associated Periodic Syndromes - pathology | Eosinophilia - drug therapy | Eosinophilia - diagnosis
EOSINOPHILIC CELLULITIS | CHURG-STRAUSS-SYNDROME | SKIN | INTERLEUKIN-5 | T-CELLS | DERMATOLOGY | Diagnosis, Differential | Humans | Treatment Outcome | Dermatologic Agents - therapeutic use | Adrenal Cortex Hormones - therapeutic use | Cryopyrin-Associated Periodic Syndromes - drug therapy | Evidence-Based Medicine | Cryopyrin-Associated Periodic Syndromes - diagnostic imaging | Dermoscopy - methods | Eosinophilia - pathology | Cryopyrin-Associated Periodic Syndromes - pathology | Eosinophilia - drug therapy | Eosinophilia - diagnosis
Journal Article
The Lancet, ISSN 0140-6736, 2003, Volume 361, Issue 9357, pp. 587 - 594
Churg-Strauss syndrome is a rare diffuse vasculitis that is almost invariably accompanied by severe asthma. Although overall prognosis is good, and treatment...
ALLERGIC GRANULOMATOSIS | MEDICINE, GENERAL & INTERNAL | SYSTEMIC VASCULITIS | ANGIITIS | MICROSCOPIC POLYANGIITIS | TERM FOLLOW-UP | INVOLVEMENT | EOSINOPHILIA | POLYARTERITIS-NODOSA | CYCLOPHOSPHAMIDE THERAPY | CORTICOSTEROID WITHDRAWAL | Churg-Strauss Syndrome - drug therapy | Diagnosis, Differential | Prognosis | Humans | Churg-Strauss Syndrome - diagnosis | Churg-Strauss Syndrome - etiology | Adrenal Cortex Hormones - therapeutic use | Churg-Strauss Syndrome - physiopathology | Physiological aspects | Churg-Strauss syndrome | Development and progression | Care and treatment | Diagnosis | Health care | Disease | Asthma | Pharmaceuticals
ALLERGIC GRANULOMATOSIS | MEDICINE, GENERAL & INTERNAL | SYSTEMIC VASCULITIS | ANGIITIS | MICROSCOPIC POLYANGIITIS | TERM FOLLOW-UP | INVOLVEMENT | EOSINOPHILIA | POLYARTERITIS-NODOSA | CYCLOPHOSPHAMIDE THERAPY | CORTICOSTEROID WITHDRAWAL | Churg-Strauss Syndrome - drug therapy | Diagnosis, Differential | Prognosis | Humans | Churg-Strauss Syndrome - diagnosis | Churg-Strauss Syndrome - etiology | Adrenal Cortex Hormones - therapeutic use | Churg-Strauss Syndrome - physiopathology | Physiological aspects | Churg-Strauss syndrome | Development and progression | Care and treatment | Diagnosis | Health care | Disease | Asthma | Pharmaceuticals
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2013, Volume 68, Issue 5, pp. 709.e1 - 709.e9
The appropriate management of the drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is paramount because it is associated with significant...
positive predictive value | Stevens-Johnson syndrome | HHV-6 | acute generalize exanthematous pustulosis | drug reaction with eosinophilia and systemic symptoms | IVIG | CMV | LTT | lymphocyte transformation test | AGEP | toxic epidermal necrolysis | DRESS | cytomegalovirus | NPV | PPV | EBV | Epstein-Barr virus | TEN | human herpesvirus-6 | intravenous immunoglobulin | SJS | negative predictive value | DIAGNOSIS | RASH | SYSTEMIC SYMPTOMS DRESS | CLINICAL-PATTERN | EOSINOPHILIA | DRUG-HYPERSENSITIVITY-SYNDROME | LYMPHOCYTE-TRANSFORMATION TEST | DERMATOLOGY | Education, Medical, Continuing | Drug Eruptions - drug therapy | Humans | Immunosuppressive Agents - therapeutic use | Drug Hypersensitivity - drug therapy | Eosinophilia - drug therapy | Syndrome
positive predictive value | Stevens-Johnson syndrome | HHV-6 | acute generalize exanthematous pustulosis | drug reaction with eosinophilia and systemic symptoms | IVIG | CMV | LTT | lymphocyte transformation test | AGEP | toxic epidermal necrolysis | DRESS | cytomegalovirus | NPV | PPV | EBV | Epstein-Barr virus | TEN | human herpesvirus-6 | intravenous immunoglobulin | SJS | negative predictive value | DIAGNOSIS | RASH | SYSTEMIC SYMPTOMS DRESS | CLINICAL-PATTERN | EOSINOPHILIA | DRUG-HYPERSENSITIVITY-SYNDROME | LYMPHOCYTE-TRANSFORMATION TEST | DERMATOLOGY | Education, Medical, Continuing | Drug Eruptions - drug therapy | Humans | Immunosuppressive Agents - therapeutic use | Drug Hypersensitivity - drug therapy | Eosinophilia - drug therapy | Syndrome
Journal Article
Allergy, ISSN 0105-4538, 09/2012, Volume 67, Issue 9, pp. 1149 - 1156
Rationale Churg–Strauss syndrome (CSS) and hypereosinophilic syndrome (HES) overlap considerably in clinical presentation. A reliable means of distinguishing...
hypereosinophilic syndrome | eosinophilia | Churg–Strauss syndrome | Churg-Strauss syndrome | ANTIBODIES | CELLS | ACTIVATION | MARKER | LEVEL | IMMUNOLOGY | EOSINOPHIL CATIONIC PROTEIN | DISEASE-ACTIVITY | EOTAXIN-3 | ALLERGY | ASTHMA | CHEMOKINE | Churg-Strauss Syndrome - metabolism | Humans | Middle Aged | Churg-Strauss Syndrome - pathology | Male | Biomarkers - blood | Young Adult | Churg-Strauss Syndrome - blood | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | Hypereosinophilic Syndrome - pathology | Interleukin-8 - blood | Hypereosinophilic Syndrome - metabolism | Chemokine CCL11 - blood | Chemokine CCL17 - blood | Hypereosinophilic Syndrome - blood | Prednisone | Corticosteroids | Biological markers | Biomarkers | Medical disorders | Eosinophilia | Hypereosinophilic syndrome
hypereosinophilic syndrome | eosinophilia | Churg–Strauss syndrome | Churg-Strauss syndrome | ANTIBODIES | CELLS | ACTIVATION | MARKER | LEVEL | IMMUNOLOGY | EOSINOPHIL CATIONIC PROTEIN | DISEASE-ACTIVITY | EOTAXIN-3 | ALLERGY | ASTHMA | CHEMOKINE | Churg-Strauss Syndrome - metabolism | Humans | Middle Aged | Churg-Strauss Syndrome - pathology | Male | Biomarkers - blood | Young Adult | Churg-Strauss Syndrome - blood | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | Hypereosinophilic Syndrome - pathology | Interleukin-8 - blood | Hypereosinophilic Syndrome - metabolism | Chemokine CCL11 - blood | Chemokine CCL17 - blood | Hypereosinophilic Syndrome - blood | Prednisone | Corticosteroids | Biological markers | Biomarkers | Medical disorders | Eosinophilia | Hypereosinophilic syndrome
Journal Article
Allergy, ISSN 0105-4538, 06/2014, Volume 69, Issue 6, pp. 798 - 805
Background Drug‐induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms (DIHS/DRESS) and Stevens–Johnson syndrome (SJS)/toxic...
human herpesvirus 6 | drug‐induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms | cytomegalovirus | Stevens–Johnson syndrome/toxic epidermal necrolysis | Epstein–Barr virus | drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms | Epstein-Barr virus | Stevens-Johnson syndrome/toxic epidermal necrolysis | ERYTHEMA MULTIFORME | Stevens-Johnson syndrome | drug rash with eosinophilia and systemic symptoms | IMMUNOLOGY | SYSTEMIC SYMPTOMS | toxic epidermal necrolysis | MYCOPLASMA-PNEUMONIAE | drug-induced hypersensitivity syndrome | ALLERGY | EOSINOPHILIA | INFECTION | COMPLICATIONS | STEVENS-JOHNSON-SYNDROME | INDUCED HYPERSENSITIVITY SYNDROME | EPSTEIN-BARR-VIRUS | Follow-Up Studies | Outcome Assessment (Health Care) | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Herpesviridae Infections - complications | Male | Viral Load | Drug Eruptions - drug therapy | Time Factors | Drug Eruptions - diagnosis | Herpesviridae - genetics | Adult | Female | Retrospective Studies | Immunosuppressive Agents - pharmacology | Herpesviridae - drug effects | Stevens-Johnson Syndrome - complications | Herpesviridae Infections - virology | Stevens-Johnson Syndrome - diagnosis | Drug Eruptions - complications | Phenotype | Virus Activation - drug effects | Aged | DNA, Viral | Genotype & phenotype | Side effects | Herpes viruses | Clinical outcomes | Steroids | Index Medicus | drug‐induced hypersensitivity syndrome | Stevens–Johnson syndrome | Original
human herpesvirus 6 | drug‐induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms | cytomegalovirus | Stevens–Johnson syndrome/toxic epidermal necrolysis | Epstein–Barr virus | drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms | Epstein-Barr virus | Stevens-Johnson syndrome/toxic epidermal necrolysis | ERYTHEMA MULTIFORME | Stevens-Johnson syndrome | drug rash with eosinophilia and systemic symptoms | IMMUNOLOGY | SYSTEMIC SYMPTOMS | toxic epidermal necrolysis | MYCOPLASMA-PNEUMONIAE | drug-induced hypersensitivity syndrome | ALLERGY | EOSINOPHILIA | INFECTION | COMPLICATIONS | STEVENS-JOHNSON-SYNDROME | INDUCED HYPERSENSITIVITY SYNDROME | EPSTEIN-BARR-VIRUS | Follow-Up Studies | Outcome Assessment (Health Care) | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Herpesviridae Infections - complications | Male | Viral Load | Drug Eruptions - drug therapy | Time Factors | Drug Eruptions - diagnosis | Herpesviridae - genetics | Adult | Female | Retrospective Studies | Immunosuppressive Agents - pharmacology | Herpesviridae - drug effects | Stevens-Johnson Syndrome - complications | Herpesviridae Infections - virology | Stevens-Johnson Syndrome - diagnosis | Drug Eruptions - complications | Phenotype | Virus Activation - drug effects | Aged | DNA, Viral | Genotype & phenotype | Side effects | Herpes viruses | Clinical outcomes | Steroids | Index Medicus | drug‐induced hypersensitivity syndrome | Stevens–Johnson syndrome | Original
Journal Article
Medicine, ISSN 0025-7974, 07/2009, Volume 88, Issue 4, pp. 236 - 243
Cardiac disease is major contributor to disease-related death in Churg-Strauss syndrome (CSS). We conducted the current study to determine the prevalence and...
EOSINOPHILIA | MEDICINE, GENERAL & INTERNAL | HYPEREOSINOPHILIC SYNDROMES | POLYARTERITIS-NODOSA | MYOCARDITIS | CARDIOVASCULAR MAGNETIC-RESONANCE | Myocarditis - etiology | Prevalence | Prognosis | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Myocarditis - drug therapy | Male | Adrenal Cortex Hormones - therapeutic use | Myocarditis - diagnosis | Young Adult | Electrocardiography | Adult | Female | Eosinophils - pathology | Retrospective Studies | Drug Therapy, Combination | Echocardiography | Cross-Sectional Studies | Myocardium - pathology | Heart Diseases - diagnosis | Magnetic Resonance Imaging | Heart Diseases - etiology | Churg-Strauss Syndrome - complications | Adolescent | Aged | Heart Diseases - drug therapy | Antibodies, Antineutrophil Cytoplasmic - blood | Churg-Strauss syndrome | Complications and side effects | Cardiomyopathy | Patient outcomes | Development and progression | Diagnosis | Research | Heart diseases
EOSINOPHILIA | MEDICINE, GENERAL & INTERNAL | HYPEREOSINOPHILIC SYNDROMES | POLYARTERITIS-NODOSA | MYOCARDITIS | CARDIOVASCULAR MAGNETIC-RESONANCE | Myocarditis - etiology | Prevalence | Prognosis | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Myocarditis - drug therapy | Male | Adrenal Cortex Hormones - therapeutic use | Myocarditis - diagnosis | Young Adult | Electrocardiography | Adult | Female | Eosinophils - pathology | Retrospective Studies | Drug Therapy, Combination | Echocardiography | Cross-Sectional Studies | Myocardium - pathology | Heart Diseases - diagnosis | Magnetic Resonance Imaging | Heart Diseases - etiology | Churg-Strauss Syndrome - complications | Adolescent | Aged | Heart Diseases - drug therapy | Antibodies, Antineutrophil Cytoplasmic - blood | Churg-Strauss syndrome | Complications and side effects | Cardiomyopathy | Patient outcomes | Development and progression | Diagnosis | Research | Heart diseases
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 11/2005, Volume 143, Issue 9, pp. 632 - 638
Background: since testing for antineutrophil cytoplasmic antibodies (ANCA) became available for routine evaluation, no large homogeneous cohort of patients...
ZAFIRLUKAST | CELLS | MEDICINE, GENERAL & INTERNAL | SYSTEMIC VASCULITIS | MONTELUKAST | ANGIITIS | EOSINOPHILIA | TERM-FOLLOW-UP | ASTHMA | GRANULOMATOSIS | Peripheral Nervous System Diseases - etiology | Severity of Illness Index | Prognosis | Prospective Studies | Cross-Sectional Studies | Humans | Middle Aged | Male | Antibodies, Antineutrophil Cytoplasmic - immunology | Heart Diseases - etiology | Churg-Strauss Syndrome - complications | Churg-Strauss Syndrome - blood | Adolescent | Churg-Strauss Syndrome - diagnosis | Fever - etiology | Adult | Female | Aged | Kidney Diseases - etiology | Churg-Strauss syndrome | Autoantibodies | Research | Testing | Disease | Medical diagnosis | Health risk assessment | Medical treatment
ZAFIRLUKAST | CELLS | MEDICINE, GENERAL & INTERNAL | SYSTEMIC VASCULITIS | MONTELUKAST | ANGIITIS | EOSINOPHILIA | TERM-FOLLOW-UP | ASTHMA | GRANULOMATOSIS | Peripheral Nervous System Diseases - etiology | Severity of Illness Index | Prognosis | Prospective Studies | Cross-Sectional Studies | Humans | Middle Aged | Male | Antibodies, Antineutrophil Cytoplasmic - immunology | Heart Diseases - etiology | Churg-Strauss Syndrome - complications | Churg-Strauss Syndrome - blood | Adolescent | Churg-Strauss Syndrome - diagnosis | Fever - etiology | Adult | Female | Aged | Kidney Diseases - etiology | Churg-Strauss syndrome | Autoantibodies | Research | Testing | Disease | Medical diagnosis | Health risk assessment | Medical treatment
Journal Article
MEDICINE, ISSN 0025-7974, 05/2009, Volume 88, Issue 3, pp. 131 - 140
Drug-induced hypersensitivity syndrome (DIHS), also called drug rash with eosinophilia and systemic symptoms (DR-ESS), is a severe reaction usually...
EOSINOPHILIC MYOCARDITIS | MEDICINE, GENERAL & INTERNAL | INFLAMMATORY-BOWEL-DISEASE | REACTIVE HEMOPHAGOCYTIC SYNDROME | 1,25-DIHYDROXYVITAMIN D-3 | HUMAN-HERPESVIRUS-6 REACTIVATION | MACROPHAGE-ACTIVATION | VITAMIN-D STATUS | ONSET STILLS-DISEASE | CONGESTIVE-HEART-FAILURE | SYSTEMIC SYMPTOMS | Hematologic Diseases - chemically induced | Glucocorticoids - therapeutic use | Calcifediol - blood | Eosinophilia - chemically induced | Vitamin D Deficiency - complications | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Risk Factors | Drug Hypersensitivity - drug therapy | Vitamin D Deficiency - drug therapy | Male | Young Adult | Vitamin D Deficiency - diagnosis | Aged, 80 and over | Drug Hypersensitivity - diagnosis | Adult | Female | Aged | Cardiovascular Diseases - chemically induced | Eosinophilia - drug therapy | Eosinophilia - diagnosis | Cohort Studies | Vitamin D deficiency | Care and treatment | Physiological aspects | Diagnosis | Research | Risk factors | Drug allergy | Index Medicus | Abridged Index Medicus
EOSINOPHILIC MYOCARDITIS | MEDICINE, GENERAL & INTERNAL | INFLAMMATORY-BOWEL-DISEASE | REACTIVE HEMOPHAGOCYTIC SYNDROME | 1,25-DIHYDROXYVITAMIN D-3 | HUMAN-HERPESVIRUS-6 REACTIVATION | MACROPHAGE-ACTIVATION | VITAMIN-D STATUS | ONSET STILLS-DISEASE | CONGESTIVE-HEART-FAILURE | SYSTEMIC SYMPTOMS | Hematologic Diseases - chemically induced | Glucocorticoids - therapeutic use | Calcifediol - blood | Eosinophilia - chemically induced | Vitamin D Deficiency - complications | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Risk Factors | Drug Hypersensitivity - drug therapy | Vitamin D Deficiency - drug therapy | Male | Young Adult | Vitamin D Deficiency - diagnosis | Aged, 80 and over | Drug Hypersensitivity - diagnosis | Adult | Female | Aged | Cardiovascular Diseases - chemically induced | Eosinophilia - drug therapy | Eosinophilia - diagnosis | Cohort Studies | Vitamin D deficiency | Care and treatment | Physiological aspects | Diagnosis | Research | Risk factors | Drug allergy | Index Medicus | Abridged Index Medicus
Journal Article